We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current GALT market cap is 162.04M. The company's latest EPS is USD -0.7244 and P/E is -3.64.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.63M | -10.34M | -9M | -9.17M | -9.56M |
| Net Income | -10.7M | -11.53M | -9.18M | -14.04M | -10.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.44M | -23.44M | -30.18M | -38.35M | -38.07M |
| Net Income | -20.18M | -23.6M | -30.7M | -38.87M | -44.81M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.29M | 20.23M | 20.08M | 22.16M | 28.2M |
| Total Liabilities | 53.48M | 62.87M | 71.21M | 73.04M | 88.44M |
| Total Equity | -33.92M | -44.37M | -52.85M | -52.6M | -61.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.47M | 29.6M | 41.83M | 21.29M | 28.2M |
| Total Liabilities | 2.87M | 5.41M | 39.21M | 53.48M | 88.44M |
| Total Equity | 43.87M | 22.47M | 893k | -33.92M | -61.96M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.06M | -10.79M | -20.63M | -28.26M | -32.97M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 10M | 10M | 20M | 30.03M | 40.03M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.85M | -20.6M | -24.31M | -31.06M | -32.97M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 50.08M | 263k | 36.81M | 10M | 40.03M |
| Market Cap | 162.04M |
| Price to Earnings Ratio | -3.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.36 |
| Price to Book Ratio | -2.71 |
| Dividend Yield | - |
| Shares Outstanding | 61.85M |
| Average Volume (1 week) | 143.39k |
| Average Volume (1 Month) | 122.83k |
| 52 Week Change | 81.94% |
| 52 Week High | 4.2684 |
| 52 Week Low | 1.28 |
| Spread (Intraday) | 7.2 (74.23%) |
| Company Name | Galectin Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.galectintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
